Planned
Ongoing
There are currently no ongoing studies in our center.
Closed
I5B-MC-JGDQ
An Open-Label, Multicenter, Phase 1a/1b Study of Olaratumab (LY3012207) Plus Pembrolizumab (MK3475) in Patients With Unresectable Locally Advanced or Metastatic Soft Tissue Sarcoma (STS) Who Have Failed Standard Treatments
- Principal investigator : Prof. Dr. Patrick Schöffski
- Back-up principal investigator : Dr. K. Punie
- More information : NCT03126591
ANITA EORTC 1506
A Phase II Multicenter Study Comparing the Efficacy of the Oral Angiogenesis Inhibitor Nintedanib With the Intravenous Cytotoxic Compound Ifosfamide for Treatment of Patients With Advanced Metastatic Soft Tissue Sarcoma After Failure of Systemic Non-oxazaphosporine-based First Line Chemotherapy for Inoperable Disease
- Principal investigator : Prof. Dr. Patrick Schöffski
- Back-up principal investigator : Dr. K. Punie
- More information : NCT02808247
ANNOUNCE I5B-MC-JGDJ
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial of Doxorubicin plus Olaratumab versus
Doxorubicin plus Placebo in Patients with Advanced or Metastatic Soft Tissue Sarcoma
- Principal investigator : Prof. Dr. Patrick Schöffski
- Back-up principal investigator : Dr. K. Punie
- More information : NCT02451943
DeFi NIR301DT
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial of Nirogacestat Versus Placebo in Adult Patients with Progressing Desmoid Tumors (DTs)/ Aggressive Fibromatosis (AF)
- Principal investigator : Prof. Dr. Patrick Schöffski
- Back-up principal investigator : Dr. K. Punie
- More information : NCT03785964
EPIZYME EZH-202
A phase II, multicenter study of the EZH2 inhibitor tazemetostat in adult subjects with INI1-negative tumors or relapsed/refractory synovial sarcoma
- Principal investigator : Prof. Dr. Patrick Schöffski
- Back-up principal investigator : Dr. K. Punie
- More information : NCT02601950
MANTRA - RAIN-3201
A Randomized Multicenter Phase 3 Study of Milademetan Versus Trabectedin in Patients
with Dedifferentiated Liposarcoma
- Principal investigator : Prof. Dr. Patrick Schöffski
- Back-up principal investigator : Dr. K. Punie
- More information : NCT04979442
TRUST EZH-501
Tazemetostat Rollover Study : An Open-Label Rollover Study
- Principal investigator : Prof. Dr. Patrick Schöffski
- Back-up principal investigator : Dr. K. Punie
- More information : NCT02875548